A Look At Cogent Biosciences (COGT) Valuation After FDA NDA Acceptance And Shifting Institutional Positions [Yahoo! Finance]
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch [Yahoo! Finance]
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding [Yahoo! Finance]
Fidelity Small Cap Growth Fund Q4 2025 Commentary [Seeking Alpha]
Cogent Biosciences (COGT) had its "outperform" rating reaffirmed by Wedbush. They now have a $55.00 price target on the stock.